Mercy Care ALBENDAZOLE. Products Affected. ALBENZA TABLET 200 MG ORAL Details. Criteria. Refer to PA Guideline for approval criteria

Similar documents
Mercy Care Plan. Acyclovir Ointment. Products Affected. acyclovir ointment 5 % external Details. Criteria. Requires use of oral Acyclovir

Acyclovir Ointment. Aetna Better Health Pennsylvania. Products Affected. acyclovir ointment 5 % external Details. Criteria

Aetna Better Health of Illinois Medicaid Formulary Updates

ALLERGIC CONJUNCTIVITIS AGENTS

DPP4 INHIBITORS. Products Affected Step 2: Janumet 50 mg-1,000 mg tablet Janumet 50 mg-500 mg tablet Januvia 100 mg tablet Januvia 25 mg tablet

DPP4 INHIBITORS. Details. Step Therapy Criteria Health Alliance Plan 2019 Date Effective: 04/01/2019

ANGIOTENSIN RECEPTOR BLOCKERS STEP THERAPY

2017 Step Therapy Criteria

JANUVIA 50 MG TABLET BYDUREON 2 MG/0.65 ML JARDIANCE 10 MG TABLET SUBCUTANEOUS PEN INJECTOR JARDIANCE 25 MG TABLET BYDUREON BCISE 2 MG/0.

Step Therapy Medications

Step Therapy Requirements

ANTICONVULSANT STEP THERAPY

Step Therapy Requirements

TABLE OF CONTENTS (Click on a link below to view the section.)

TABLE OF CONTENTS (Click on a link below to view the section.)

APREPITANT ARMODAFINIL BELSOMRA BUPAP BUPRENORPHINE HCL BUTALBITAL-ACETAMINOPHEN BUTALBITAL-APAP-CAFF-COD BUTALBITAL-APAP-CAFFEINE

ALLERGIC RHINITIS-NASAL

ANTIDIABETIC AGENTS - MISCELLANEOUS

ANTIDIABETIC AGENTS - MISCELLANEOUS

Tribute 2018 Formulary 2018 Quantity Limit Criteria

2018 Step Therapy FID 18088

Step Therapy Requirements. Effective: 05/01/2018

ANTIDIABETIC AGENTS - MISCELLANEOUS

ANTIDEPRESSANTS. Details. dose pack Viibryd 10 mg tablet Viibryd 20 mg tablet Viibryd 40 mg tablet. Criteria

TABLE OF CONTENTS (Click on a link below to view the section.)

Step Therapy Requirements. Effective: 11/01/2018

ARBS MEDICATION(S) SUBJECT TO STEP THERAPY DIOVAN HCT MG TAB, DIOVAN HCT MG TABLET

Tribute 2018 Formulary 2018 Quantity Limit Criteria

ATYPICAL ANTIPSYCHOTICS

TABLE OF CONTENTS (Click on a link below to view the section.)

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 04/01/2019

Kansas Health Advantage (HMO SNP) 2018 Formulary Quantity Limit Criteria

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 01/01/2017

Y0133_StepTherapyCriteria _C 10/18/18 Y0133_StepTherapyCriteria _C es 10/18/18

Step Therapy Requirements

AETNA BETTER HEALTH January 2017 Formulary Change(s)

ANTICONVULSANTS. Details

Umpqua Health Alliance (OHP) Formulary Changes January 2018

ANTICONVULSANTS. Details

5-ASA. Products Affected DIPENTUM 250 MG CAPSULE LIALDA 1.2 GRAM TABLET,DELAYED RELEASE. Details

5-ASA. Products Affected. Details. Dipentum 250 mg capsule. Lialda 1.2 gram tablet,delayed release

WellCare s South Carolina Preferred Drug List Update

2014 Step Therapy Criteria (List of Step Therapy Criteria)

FirstCarolinaCare Insurance Company. Step Therapy Requirements

Santa Clara Family Health Plan Cal MediConnect Formulary. List of Step Therapy Requirements Effective: 12/01/ E

ANTICONVULSANTS. Details

ANTICONVULSANTS. Details

CRITERIA Trial of two generic formulary products from the following: atomoxetine or ADHD stimulant medication.

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

ANTICONVULSANTS. Details. Step Therapy Criteria Date Effective: April 1, 2019

March 2018 P & T Updates

OHIO MEDICAID PHARMACY COVERAGE

AETNA BETTER HEALTH January 2017 Formulary Change(s)

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

Medicare Part D Drugs that Require Step Therapy Effective 12/01/2017

2015 Step Therapy Prior Authorization Medical Necessity Guidelines

JULY 2017 ADDITIONS. NP Thyroid 120mg NP Thyroid 15mg JUNE 2017 CHANGES

Quarterly pharmacy formulary change notice

ACYCLOVIR OINT (CCHP2017)

Quarterly pharmacy formulary change notice

Step Therapy Requirements. Effective: 1/1/2019

ALPHA GLUCOSIDASE INHIBITOR THERAPY

5-ASA. Products Affected Dipentum 250 mg capsule. Details. Lialda 1.2 gram tablet,delayed release

Quarterly pharmacy formulary change notice

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

ACYCLOVIR OINT (CCHP2017)

2014 Quantity Limits (QL) Criteria

ACYCLOVIR OINT (CCHP2017)

ICP Formulary Updates

Quarterly pharmacy formulary change notice

Neighborhood Medicaid Formulary Changes: June 2017

HEALTH SHARE/PROVIDENCE (OHP)

Drug Formulary Update, January 2018 Commercial and State Programs

ANGIOTENSIN RECEPTOR BLOCKERS

Step Therapy Criteria (Criteria for Step Therapy-2 [ST-2] Drugs)

There have been no updates to the Aetna Better Health of MI formulary for February

DT Description Price Category Price change Percentage BNF 1.2 Mebeverine 135mg tablets (100) 759 M %

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Farm Bureau Health Plans Date Effective: November 1, 2018.

Peach State Health Plan routinely reviews the medications available on the Preferred Drug

2018 Step Therapy (ST) Criteria

STEP THERAPY CRITERIA

THERAPEUTIC AREA NAME STRENGTH DOSAGE FORM

STEP THERAPY IN MEDICARE PART D

ADHD STIMULANTS - SCORE

Removed from formulary. Removed from formulary. Added to formulary. Quanitity limit changed. Removed from formulary. Removed from formulary

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 01/01/2017

High-Cost Drug Exclusions

Transcription:

ALBENDAZOLE Mercy Care ALBENZA TABLET 200 MG ORAL Refer to PA Guideline for approval criteria 1

BRIMONIDINE-TIMOLOL COMBIGAN SOLUTION 0.2-0.5 % OPHTHALMIC Requires use of separate ingredients for at least 30 days in the previous 130 days 2

BRINZOLAMIDE OPHTH AZOPT SUSPENSION 1 % OPHTHALMIC Requires use of dorzolamide for at least 30 days in the previous 130 days 3

CELECOXIB celecoxib capsule 100 mg oral celecoxib capsule 200 mg oral celecoxib capsule 400 mg oral celecoxib capsule 50 mg oral Refer to PA Guideline for approval criteria 4

DIABETES INVOKAMET TABLET 150-1000 MG ORAL INVOKAMET TABLET 150-500 MG ORAL INVOKAMET TABLET 50-1000 MG ORAL INVOKAMET TABLET 50-500 MG ORAL INVOKANA TABLET 100 MG ORAL INVOKANA TABLET 300 MG ORAL JARDIANCE TABLET 10 MG ORAL JARDIANCE TABLET 25 MG ORAL SYNJARDY TABLET 12.5-1000 MG ORAL SYNJARDY TABLET 12.5-500 MG ORAL SYNJARDY TABLET 5-1000 MG ORAL SYNJARDY TABLET 5-500 MG ORAL SYNJARDY XR TABLET EXTENDED RELEASE 24 HOUR 10-1000 MG ORAL SYNJARDY XR TABLET EXTENDED RELEASE 24 HOUR 12.5-1000 MG ORAL SYNJARDY XR TABLET EXTENDED RELEASE 24 HOUR 25-1000 MG ORAL SYNJARDY XR TABLET EXTENDED RELEASE 24 HOUR 5-1000 MG ORAL Requires use of Metformin for at least 60 days in the previous 130 days 5

Differin OTC adapalene cream 0.1 % external tretinoin cream 0.025 % external tretinoin cream 0.05 % external tretinoin cream 0.1 % external tretinoin gel 0.01 % external tretinoin gel 0.025 % external Requires use of OTC Differin 0.1% gel for at least 30 days in the previous 130 days 6

EZETIMIBE ezetimibe tablet 10 mg oral Requires use of a statin for at least 60 days in the previous 130 days 7

FEBUXOSTAT ULORIC TABLET 40 MG ORAL ULORIC TABLET 80 MG ORAL Requires use of allopurinol for at least 30 days in the previous 130 days 8

ICS Combination Inhalers ADVAIR DISKUS AEROSOL POWDER BREATH ACTIVATED 100-50 MCG/DOSE INHALATION ADVAIR DISKUS AEROSOL POWDER BREATH ACTIVATED 250-50 MCG/DOSE INHALATION ADVAIR DISKUS AEROSOL POWDER BREATH ACTIVATED 500-50 MCG/DOSE INHALATION ADVAIR HFA AEROSOL 115-21 MCG/ACT INHALATION ADVAIR HFA AEROSOL 230-21 MCG/ACT INHALATION ADVAIR HFA AEROSOL 45-21 MCG/ACT INHALATION DULERA AEROSOL 100-5 MCG/ACT INHALATION DULERA AEROSOL 200-5 MCG/ACT INHALATION SYMBICORT AEROSOL 160-4.5 MCG/ACT INHALATION SYMBICORT AEROSOL 80-4.5 MCG/ACT INHALATION Requires use of a steroid inhaler for at least 30 days in the previous 130 days 9

ISOTRETINOIN MYORISAN CAPSULE 10 MG ORAL MYORISAN CAPSULE 20 MG ORAL MYORISAN CAPSULE 30 MG ORAL MYORISAN CAPSULE 40 MG ORAL ZENATANE CAPSULE 10 MG ORAL ZENATANE CAPSULE 20 MG ORAL ZENATANE CAPSULE 30 MG ORAL ZENATANE CAPSULE 40 MG ORAL Requires use of oral minocycline or doxycycline for at least 30 days in the previous 130 days. In addition, cannot have a claim for adapalene or topical tretinoin in the past 30 days 10

Lice malathion lotion 0.5 % external SKLICE LOTION 0.5 % EXTERNAL spinosad suspension 0.9 % external Requires use of permethrin or pyrethrin in the previous 30 days 11

LINACLOTIDE LINZESS CAPSULE 145 MCG ORAL LINZESS CAPSULE 290 MCG ORAL LINZESS CAPSULE 72 MCG ORAL Requires use of lactulose, PEG3350, or dicyclomine for at least 30 days in the previous 130 days 12

MILNACIPRAN SAVELLA TABLET 100 MG ORAL SAVELLA TABLET 12.5 MG ORAL SAVELLA TABLET 25 MG ORAL SAVELLA TABLET 50 MG ORAL SAVELLA TITRATION PACK 12.5 & 25 & 50 MG ORAL Requires use of duloxetine for at least 60 days in the previous 130 days 13

MOMETASONE NASAL mometasone furoate suspension 50 mcg/act nasal Requires use of any 2 of the following: fluticasone, triamcinolone, or budesonide for at least 30 days in the previous 130 days 14

OMEGA-3-ACID omega-3-acid ethyl esters capsule 1 gm oral Requires use of OTC FISH OIL for at least 60 days in the previous 130 days 15

Ophthalmic Antihistamines azelastine hcl solution 0.05 % ophthalmic epinastine hcl solution 0.05 % ophthalmic olopatadine hcl solution 0.1 % ophthalmic olopatadine hcl solution 0.2 % ophthalmic Requires use of ketotifen for at least 15 days in the previous 90 days 16

PARICALCITOL paricalcitol capsule 1 mcg oral paricalcitol capsule 2 mcg oral paricalcitol capsule 4 mcg oral Requires use of Calcitriol for at least 30 days in the previous 130 days 17

RAMELTEON ROZEREM TABLET 8 MG ORAL Requires use of both zolpidem and temazepam for at least 15 days in the previous 130 days 18

ROSIGLITAZONE AVANDIA TABLET 2 MG ORAL AVANDIA TABLET 4 MG ORAL Requires use of Metformin and Pioglitazone for at least 60 days in the previous 130 days 19

ROSUVASTATIN rosuvastatin calcium tablet 10 mg oral rosuvastatin calcium tablet 20 mg oral rosuvastatin calcium tablet 40 mg oral rosuvastatin calcium tablet 5 mg oral Requires use of atorvastatin for at least 60 days in the previous 130 days 20

TADALAFIL tadalafil (pah) tablet 20 mg oral Requires use of Sildenafil for at least 30 days in the previous 130 days 21

Topical Calcinurin Inhibitors ELIDEL CREAM 1 % EXTERNAL tacrolimus ointment 0.03 % external tacrolimus ointment 0.1 % external Requires Requires use of of 2 topical steroids for at least 14 days in the previous 130 days 22

URINARY ANTICHOLINERGICS tolterodine tartrate er capsule extended release 24 hour 2 mg oral tolterodine tartrate er capsule extended release 24 hour 4 mg oral tolterodine tartrate tablet 1 mg oral tolterodine tartrate tablet 2 mg oral trospium chloride er capsule extended Requires use of oxybutynin or trospium IR for at least 30 days in the previous 130 days 23

24